Skip to content
★ Sign in to follow
AD
Total declarations
8
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€33k

Latest filing published 29 Jun 2022 for Dr. Lal Path Labs Ltd., €1,695.

Filing timeline

BuySale
Alok Dadhich

Alok Dadhich: trading record in brief

All filings by Alok Dadhich on record concern Dr. Lal Path Labs Ltd., in the capacity of chief executive. The record holds 8 filings, for trades running from 9 August 2021 to 27 May 2022.

Every open-market trade on record is a sale: 4 sales worth €33k. Other entries cover 4 share grants. In 2022 alone, the filings show no purchases and 2 sales.

On 29 June 2022 came the latest disclosure, an open-market sale for €1,695 in Dr. Lal Path Labs Ltd. The median gap between a trade and its publication by SEBI (PIT + SAST) is 18 days. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Alok Dadhich

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    140,525 INR14SEBI
    70 shares@ ₹2,007.505.2% of flowEquity SharesSEBI:d471393c5e8fa52a05b2f478cdcba8fbd17d6c25
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    546,710 INR15SEBI
    250 shares@ ₹2,186.8420.0% of flowEquity SharesSEBI:790de4fd1e3b505d420abaabc7e8cd63798f5f61
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    800 INR13SEBI
    80 shares@ ₹10.000.0% of flowEquity SharesSEBI:bc4eedf83e7c7f4efa53ccaef235c3bc7fd547eb
    Canonical exit: 22 Aug 2022 (T+90)
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    1,700 INR13SEBI
    170 shares@ ₹10.000.1% of flowEquity SharesSEBI:d28660ba9e1b0cb85c6273ea6a677ecc247b381e
    Canonical exit: 8 Aug 2022 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR10SEBI
    300 shares@ ₹3,836.66670.0000% mcap53.9% of flowEquity SharesSEBI:143c041f3e917561dcc2873dfacd274f046656dc
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    6,500 INR2SEBI
    650 shares@ ₹10.000.0000% mcap0.3% of flowEquity SharesSEBI:c67abe4d193fc0e11c89e1dec2132b35ff789a52
    Canonical exit: 14 Nov 2021 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    975,650 INR7SEBI
    250 shares@ ₹3,902.600.0000% mcap45.7% of flowEquity SharesSEBI:d20ffe1b1a2e098bfa138403ddcb250fdbbce8f9
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    2,500 INR2SEBI
    250 shares@ ₹10.000.0000% mcap0.1% of flowEquity SharesSEBI:8c961d80310b1f7195c28455abe1f649ff831b7c
    Canonical exit: 7 Nov 2021 (T+90)

8 of 8 declarations